All news is rigorously fact-checked and reviewed by leading blockchain experts and seasoned industry insiders.
- Ripple is no longer under the SEC’s “Bad Actor” restriction, reopening its ability to conduct exempt securities sales.
- Public companies began incorporating XRP into their treasury plans in 2024, and the end of the SEC lawsuit is going to fuel more adoption.
The U.S. Securities and Exchange Commission (SEC) has officially lifted the “bad actor” disqualification that had barred Ripple from conducting exempt securities offerings under Regulation D.
For context, under Rule 506(d) of Regulation D, certain individuals or companies involved in securities offerings, like issuers, executives, directors, or promoters, can be disqualified from using the fast-track, exemption-based fundraising method if they’ve been involved in disqualifying events.
This involves securities fraud, injunctions, or regulatory sanctions. This was introduced in 2013 under the Dodd-Frank Act to keep tainted offerings out of the private capital market.
Ripple’s legal battle with the SEC began in December 2020, when the SEC accused the company of selling XRP as unregistered securities. In July 2023, a mixed ruling determined that institutional sales of XRP counted as securities sales, while publicly traded XRP did not.
Ripple was subsequently hit with a $125 million fine, along with an injunction affecting institutional offerings. This triggered the Bad Actor disqualification under Rule 506(d), effectively barring Ripple from using the Regulation D fundraising avenue.
This waiver now restores Ripple’s ability to raise private capital from accredited investors, reopening a fast-track fundraising channel without the need for full SEC registration. Evidently, this decision signals a more flexible, case-by-case approach from the SEC toward compliant crypto firms. Paul Atkin, the current SEC chair, has taken a 360 turn from how things were run during Gray Gensler’s tenure.
Boost for Institutional Confidence
On an X post, Legal expert Bill Morgan praised it as a “major win,” noting it clears legal hurdles and enables Ripple to more readily attract institutional investment. He added that,
It may also help Ripple achieve broader business objectives, including its application for a national bank charter.
In June, Crypto News Flash reported that Ripple submitted its application for a national banking license to oversee the operations of its 8-month-old stablecoin RLUSD, and also has access to the Federal Reserve’s payment system.
It’s important to note that the underlying injunction and the $125 million fine remain in place. The waiver doesn’t equate to a full legal exoneration, nor does it set a binding legal precedent for the broader crypto industry.
Bill Morgan has pointed out that more companies are warming up to the idea of holding XRP on their balance sheets. Quantum Biopharma Ltd, which previously held Bitcoin (BTC), Dogecoin (DOGE), and Solana (SOL), has expanded its crypto holdings to include XRP and Ethereum (ETH).
In Japan, SBI’s Ripple investment and XRP assets have reached an estimated value of ¥1.6 trillion ($10 billion).
As Crypto News Flash notes, institutional interest is building, and Trident Digital Tech Holdings Ltd (NASDAQ: TDTH) is planning a $500 million raise to develop a large corporate XRP treasury. Webus announced on July 1 that it had reached a conditional Securities Purchase Agreement with Ripple Strategy Holdings, providing potential access to $100 million in senior equity funding.
At the moment, XRP is trading around $3.33, up 10% in the past week and edging close to its all-time high of $3.84 set eight years ago. If the momentum continues, new price records of $5 and $10 could be on the horizon.
